Supplement and ingestible ad positioning (Meta + Google)
By Spear Systems · 2 min read ·
Supplements and ingestibles can run on both platforms — but copy that implies diagnosis, treatment, or prevention of disease flips the product into a claim the advertiser can’t substantiate, and the ad fails.
The tripwires
- Treatment framing: any suggestion the product diagnoses, treats, or prevents a named condition. Describe what the product is and how it’s used, not what disease outcome it produces.
- Outcome promises: covered in the claims guide — no specific results in set timeframes without qualifiers.
- Viewer attribution: “your gut issues” style copy triggers the personal-attributes rule on top of the claim problem. One sentence can violate twice.
- Prescription adjacency: weight-loss products requiring prescription fall under Meta’s Drugs and Pharmaceuticals policy (geo-targeting, written permission) and Google’s healthcare certification routes (e.g. LegitScript-gated categories). Don’t position an Rx-adjacent product as a casual supplement.
Positioning that passes
General-wellbeing framing (fitness support, daily nutrition, lifestyle) with honest process language, 18+ targeting, and a landing page that matches the ad’s modesty — stronger claims on the page than in the ad trigger restrictions even when the creative is compliant (page checklist).
Overview: health ads hub.
Sources
- Meta Transparency Center, Health and Wellness policy (changelog Jul 22, 2026; accessed 2026-09-24)
- Google Ads Help, Unreliable claims + Healthcare and Medicines policies (accessed 2026-09-24)